Imunon, Inc. Insider Trading

IMNN

Last 12 months

Insiders sold 38K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. General Counsel and Corp Sec Susan Eylward sold 21K on Jun 29, 80% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2024.

Net open-market

−38K

0 buys · 6 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Aug 2024

Aug 20, 2024

Get an email when IMNN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 31	Susan Eylward General Counsel and Corp Sec	SoldNo plan	2,525	$1.56	4K	47%	Form 4
Aug 17	Susan Eylward General Counsel and Corp Sec	SoldNo plan	2,449	$1.63	4K	46%	Form 4
Aug 3	Susan Eylward General Counsel and Corp Sec	SoldNo plan	2,541	$1.57	4K	47%	Form 4
Jul 20	Susan Eylward General Counsel and Corp Sec	SoldNo plan	2,150	$1.78	4K	43%	Form 4
Jul 6	Susan Eylward General Counsel and Corp Sec	SoldNo plan	920	$1.88	2K	24%	Form 4
Jun 29	Susan Eylward General Counsel and Corp Sec	SoldNo plan	11,800	$1.75	21K	80%	Form 4

Aug 31No plan
Susan Eylward
General Counsel and Corp Sec · sold 2,525 at $1.56
4K
47% of stake
Aug 17No plan
Susan Eylward
General Counsel and Corp Sec · sold 2,449 at $1.63
4K
46% of stake
Aug 3No plan
Susan Eylward
General Counsel and Corp Sec · sold 2,541 at $1.57
4K
47% of stake
Jul 20No plan
Susan Eylward
General Counsel and Corp Sec · sold 2,150 at $1.78
4K
43% of stake
Jul 6No plan
Susan Eylward
General Counsel and Corp Sec · sold 920 at $1.88
2K
24% of stake
Jun 29No plan
Susan Eylward
General Counsel and Corp Sec · sold 11,800 at $1.75
21K
80% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IMNN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with IMNN

CompareIntrinsic value

MREOMereo BioPharma Group plc

$0.30+4.12%10

VYNEVyne Therapeutics Inc.

$14.91-18.84%25

QUCYQuantum Cyber N.V.

$0.74+2.62%10

ELABPMGC Holdings Inc.

$1.92-1.03%20

MNOVMediciNova Inc.

$1.45+2.11%40

CANFCan-Fite BioPharma Ltd.

$1.67+3.02%20

VCNXVaccinex, Inc.

$0.70-1.39%10

LIPOLipella Pharmaceuticals Inc.

$0.00+0.00%25

Spot a number that looks wrong? Check it in IMNN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IMNN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.